FDA Approves Synribo (Omacetaxine) for CML | Zendy

AI Assistant Blog Pricing

Open Access

FDA Approves Synribo (Omacetaxine) for CML

Publication year - 2012

Publication title -

oncology times

Language(s) - Uncategorized

Resource type - Journals

eISSN - 1548-4688

pISSN - 0276-2234

DOI - 10.1097/01.cot.0000423797.72942.28

Subject(s) - medicine , virology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Empowering knowledge with every search

About

About Careers Publisher Partners Contact Us

Learn

FAQs Blog Terms of Use Privacy Policy

Discover

Explore

Copyright Knowledge E © 2025. All Rights Reserved.